Nuwellis, Inc.
NUWECIK 0001506492 · Electromedical & Electrotherapeutic Apparatus · Nasdaq
- CHF Solutions, Inc. (until 2021-04-16)
- Sunshine Heart, Inc. (until 2017-05-23)
Revenue (TTM)
$8.25M
−5.4% YoY
Q1 May 2026
Net Income (TTM)
−$19.64M
−56.9% YoY
Q1 May 2026
EPS Diluted (TTM)
−$91.55
+92.8% YoY
Q1 May 2026
Gross Margin
62.5%
Q1 May 2026
Operating Margin
-160.4%
Q1 May 2026
Net Margin
-238.1%
Q1 May 2026
Free Cash Flow (TTM)
−$14.69M
Q1 May 2026
Cash
$2.08M
Q1 May 2026
Total Debt
$5.9M
Q1 May 2026
Shares Outstanding
2.68M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
Moderate Neutral
Nuwellis (NUWE) Appoints Mike McCormick as CEO
Mike McCormick becomes chief executive of the medical technology company effective June 30, 2026, replacing John Erb, who transitions to chairman.